HHS vs HMN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
HHS
64.8
AI Score
VS
HHS Wins
HMN
30.9
AI Score
Investment Advisor Scores
HMN
31score
Recommendation
SELL
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | HHS | HMN | Winner |
|---|---|---|---|
| Revenue | 75.25M | 1.31B | HMN |
| Net Income | -5.63M | 141.30M | HMN |
| Net Margin | -7.5% | 10.8% | HMN |
| ROE | -36.7% | 9.9% | HMN |
| ROA | -6.4% | 0.9% | HMN |
| Total Assets | 88.06M | 15.40B | HMN |
| Cash | 5.18M | 148.80M | HMN |
Relative Price Performance (Last 90 Days)
HHS 1M: -6.9%
· 3M: -6.3%
HMN 1M: +15.4%
· 3M: +0.6%
Current Technical Phase
HHS
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
HMN
NeutralHold
Mixed signals - no dominant trend phase, RSI 71
Fundamentals Snapshot
| Metric | HHS | HMN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 3.8 | 9.8 |
| Trailing P/E | — | 12.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.2% | 0.4% |
| Operating Margin | 0.0% | 0.1% |
| EPS | -0.77 | 4.27 |
| Dividend Yield | — | 0.03% |
Frequently Asked Questions
Based on our detailed analysis, HHS is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.